Chinese expert consensus on drug-coated balloon for the treatment of symptomatic intracranial atherosclerotic stenosis
10.3969/j.issn.1672-5921.2025.11.008
- VernacularTitle:药物涂层球囊治疗症状性颅内动脉粥样硬化性狭窄中国专家共识
- Author:
Tianxiao LI
;
Liqun JIAO
;
Zhongrong MIAO
;
Jianmin LIU
- Collective Name:Neurointerventional Professional Committee of Chinese Congress;Chinese College of Interventionalists;Interventional Neuroradiology Branch of Chinese Stroke Association
- Publication Type:Journal Article
- Keywords:
Drug-coated balloon;
Symptomatic intracranial atherosclerotic stenosis;
Ischemic stroke;
Endovascular interventional angioplasty;
Consensus
- From:
Chinese Journal of Cerebrovascular Diseases
2025;22(11):794-804
- CountryChina
- Language:Chinese
-
Abstract:
Endovascular interventional angioplasty is an important treatment for symptomatic intracranial atherosclerotic stenosis(sICAS).However,conventional endovascular interventions,such as bare-metal stenting and plain balloon angioplasty,are associated with a high risk of restenosis.Drug-coated balloon(DCB),due to the drug-carrying properties,may reduce the long-term restenosis risk and represent a novel option for the endovascular intervention of sICAS.Presently,DCB for sICAS has been a subject of increasing clinical studies,and its clinical application has progressed to small-scale use.Nevertheless,it's lack of an unified guidelines or consensus to standardize its procedural indications,technical details,and perioperative management.This expert consensus summarized the relevant clinical studies on DCB for sICAS and incorporated the practical experience of specialists from neurointerventional field,aiming to provide reasonable guidance for the current clinical use of DCB in treating sICAS.
